Health specialists and regulatory affairs from around the world will meet from November 27 to 29 at Centro Citibanamex, Mexico City, to share knowledge and experiences about current and future threats to global health, the role of Regulatory Science and Good Health Regulatory Practices to achieve Universal Health Coverage through innovation, harmonization and regulatory convergence; dissemination and use of internationally recognized standards, learning, training and exchange of experiences in regulation and health practices.

OBJECTIVES

• Share the experiences of harmonization and regulatory convergence.
• Update the progress of Regulatory Science and Good Regulatory Practices of other countries and regional and international regulatory networks.
• Promote the population’s access to safer, more efficient and high quality products, improve the quality of health services, and promote the prevention of diseases.
• Improve cooperation and dissemination of knowledge of Regulatory Science and Good Regulatory Practices for access to health products and technologies, innovation in new therapies or related technologies, thus improving the current regulatory environment.

TOPICS TO ADDRESS
1. Emerging global threats to health.
2. Regulatory science and its contribution to health.
3. Harmonization, convergence, trust and international standards.
4. Policy and good regulatory practices.
5. Professional competences for regulatory professionals.

For more information go to https://www.dropbox.com/s/8lyniy59fvetkn7/Programa%20R%C3%A1pido%20SSI_ESP%20ING%20Interactivo_ok.pdf?dl=0

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!

On Tuesday, November 6, 2018, at 1pm (EST), CDER’s Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: FDA Drug Topics: FDA Regulation of Color Additives in Drug Products. The U.S. Food and Drug Administration (FDA) regulates color additives under the authority of the Federal Food, Drug, and Cosmetic Act. Color additives must be pre-approved by the FDA and listed in Title 21 of the Code of Federal Regulations before they may be used in drugs and other FDA-regulated products. This webinar will give you an overview of FDA’s regulation of color additives in drug products. You will learn about the color additive petition process and how a color additive is listed for use in drugs. You will also learn about the two types of color additives, certified and certification exempt, and how the certification process works. The webinar will discuss the labeling requirements for color additives in drug products and how FDA enforces these regulations.

For more information go to https://www.fda.gov/AboutFDA/WorkingatFDA/FellowshipInternshipGraduateFacultyPrograms/PharmacyStudentExperientialProgramCDER/ucm623480.htm

Source: https://www.moh.gov.jm/9th-annual-national-health-research-conference-2018/ 

A total of 152 profiles were eliminated by the social network Facebook, Inc., for advertising and marketing products that violate Colombian laws and regulations putting the health of the consuming population at risk.

This measure was achieved thanks to a request sent by the National Institute for Food and Drug Surveillance (INVIMA) in which concerns are expressed about these ads for products that lack the sanitary registration or health permit required, offer unauthorized benefits and virtues. therapies that deceive consumers.

Within the URLs removed are products to “burn fat” and achieve weight loss, the brand Ultrasbelt – U.USB with different commercial presentations and marketing in several cities in Colombia.

Also, products of the brand XIBION, Eurofit and Ultra ZX, Nitro Fit, Airt Fit, Green Tea, Sundown Naturals, Ghee Butter, Blue Energy, among others. All were offered with quick and easy results to “burn fat and lose weight”.

For more information go to https://www.invima.gov.co/por-solicitud-de-invima,-facebook-elimina-152-perfiles-que-anunciaban-y-comercializaban-productos-enga%C3%B1osos-en-colombia

The Minister of Health, Emilio Santelices, together with the representative of WHO in Chile, Paloma Cuchí and the Director (s) of the Institute of Public Health (ISP), Judith Mora, were in charge of opening the 7th Global Meeting on Vaccine Safety, organized by the World Health Organization (WHO), which included the participation of the ISP.

The event involved around 100 attendees, from more than 40 countries representing immunization programs and regulatory authorities, whose main objective is to develop, update and competencies in pharmacovigilance of vaccines that allow access to safe vaccines in each of the member countries.

The purpose of the meeting was to interact and exchange information on the progress of the last year in the implementation of the national and global pharmacovigilance of vaccines.

More information by the link http://www.ispch.cl/noticia/27323

PAHO video production in commemoration of the 40 years of Alma-Ata

• More information 56th Directing Council of PAHO

With the participation of more than 80 representatives of Advertising Agencies, Law Firms and Pharmaceutical Houses, the Ministry of Health (MINSA) held an important discussion on Resolution No. 1293, of June 20, 2018, which approves the Internal Regulation of the Advertising and Propaganda Commission, focused on the procedures of approval of advertising and propaganda in the media for the approval or not of materials related to products, materials, equipment or services that have an impact on the health of the population of the Republic of Panama.

For more information go to : http://www.minsa.gob.pa/noticia/discuten-aspectos-de-resolucion-del-minsa-para-aprobacion-de-publicidad-y-propaganda-en